Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nystagmus.

I Gottlob1

  • 1Department of Strabismus and Neuro-Ophthalmology, Kantonsspital St. Gallen, Switzerland.

Current Opinion in Ophthalmology
|July 1, 1999
PubMed
Summary
This summary is machine-generated.

This review highlights advances in understanding and treating nystagmus, focusing on early-onset and acquired forms. New insights into oscillopsia suppression and pharmacological treatments like gabapentin offer improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Management of nystagmus in children: a review of the literature and current practice in UK specialist services.

Eye (London, England)·2020
Same author

Management of nystagmus in children: a review of the literature and current practice in UK specialist services.

Eye (London, England)·2020
Same author

An audit of the outcome of amblyopia treatment: a retrospective analysis of 322 children.

The British journal of ophthalmology·2009
Same author

Eye movement involvement in Parry-Romberg Syndrome: a clinicopathologic case report.

Strabismus·2008
Same author

Reduction of congenital nystagmus in a patient after smoking cannabis.

Strabismus·2008
Same author

Nystagmus characteristics in congenital stationary night blindness (CSNB).

The British journal of ophthalmology·2008
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Area of Science:

  • Ophthalmology
  • Neurology
  • Neuroscience

Background:

  • Nystagmus, an involuntary eye movement disorder, presents in early-onset and acquired forms, impacting vision and quality of life.
  • Oscillopsia, the sensation of visual instability, is a common symptom associated with nystagmus.

Purpose of the Study:

  • To review significant research advancements in the past year concerning early-onset and acquired neurological nystagmus.
  • To highlight progress in understanding nystagmus mechanisms and treatment strategies.

Main Methods:

  • Literature review of key scientific papers published within the last year.
  • Focus on studies investigating the pathophysiology and therapeutic interventions for various nystagmus types.

Main Results:

Related Experiment Videos

  • Significant progress in understanding the mechanisms of oscillopsia suppression in early-onset nystagmus.
  • Advances in the treatment of periodic alternating nystagmus and nystagmus associated with albinism.
  • Demonstrated efficacy of gabapentin (a gamma-aminobutyric acid agonist) and memantine (a glutamate antagonist) in treating acquired neurological nystagmus.

Conclusions:

  • Recent research has expanded our knowledge of nystagmus, particularly in early-onset and acquired neurological conditions.
  • Pharmacological interventions show promise for managing acquired nystagmus, offering new therapeutic avenues.